During the last session, Essa Pharma Inc (NASDAQ:EPIX)’s traded shares were 0.36 million, with the beta value of the company hitting 1.70. At the end of the trading day, the stock’s price was $1.83, reflecting an intraday gain of 3.98% or $0.07. The 52-week high for the EPIX share is $11.67, that puts it down -537.7 from that peak though still a striking 23.5% gain since the share price plummeted to a 52-week low of $1.40. The company’s market capitalization is $81.20M, and the average intraday trading volume over the past 10 days was 0.48 million shares, and the average trade volume was 807.12K shares over the past three months.
Essa Pharma Inc (NASDAQ:EPIX) trade information
Essa Pharma Inc (EPIX) registered a 3.98% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 3.98% in intraday trading to $1.83, hitting a weekly high. The stock’s 5-day price performance is 6.40%, and it has moved by -69.35% in 30 days. Based on these gigs, the overall price performance for the year is -67.26%. The short interest in Essa Pharma Inc (NASDAQ:EPIX) is 1.15 million shares and it means that shorts have 30.53 day(s) to cover.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The consensus price target of analysts on Wall Street is $9.5, which implies an increase of 80.74% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $2 and $17 respectively. As a result, EPIX is trading at a discount of -828.96% off the target high and -9.29% off the low.
Essa Pharma Inc (EPIX) estimates and forecasts
Statistics show that Essa Pharma Inc has underperformed its competitors in share price, compared to the industry in which it operates. Essa Pharma Inc (EPIX) shares have gone down -71.36% during the last six months, with a year-to-date growth rate less than the industry average at -16.67% against 16.60.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 25.04%. While earnings are projected to return -13.00% in 2024.
EPIX Dividends
Essa Pharma Inc is due to release its next quarterly earnings in December. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Essa Pharma Inc (NASDAQ:EPIX)’s Major holders
Essa Pharma Inc insiders own 2.26% of total outstanding shares while institutional holders control 81.19%, with the float percentage being 83.07%. BVF INC/IL is the largest shareholder of the company, while 39.0 institutions own stock in it. As of 2024-06-30, the company held over 8.75 million shares (or 19.7767% of all shares), a total value of $46.02 million in shares.
The next largest institutional holding, with 7.89 million shares, is of BELLEVUE GROUP AG’s that is approximately 17.8348% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $41.5 million.
Also, the Mutual Funds coming in first place with the largest holdings of Essa Pharma Inc (EPIX) shares are Avantis U.S. Small Cap Equity ETF and Fidelity NASDAQ Composite Index Fund . Data provided on Sep 30, 2024 indicates that Avantis U.S. Small Cap Equity ETF owns about 46.65 shares. This amounts to just over 0.11 percent of the company’s overall shares, with a $85373.0 market value. The same data shows that the other fund manager holds slightly less at 26.86, or about 0.06% of the stock, which is worth about $49150.0.
